There are 1076 resources available
Immune checkpoint inhibitor toxicities: What we know about mechanisms of action and current trends in management
Presenter: Joycelyn Lee
Session: Have we seen everything from checkpoints inhibitors?
Resources:
Slides
Webcast
New checkpoint inhibitors and combinations beyond PD1/PDL1
Presenter: Elena Garralda
Session: Have we seen everything from checkpoints inhibitors?
Resources:
Slides
Webcast
Refining patient selection: Benefits and risks of treating unselected patient groups
Presenter: Seock-Ah Im
Session: Targeting DNA damage response (DDR): Next generation drugs and the importance of biomarkers
Resources:
Slides
Webcast
New guidelines for NPC staging: Do they impact practice?
Presenter: Brigette Ma
Session: Nasopharyngeal cancer (NPC): Treatment strategies for locally advanced disease
Resources:
Slides
Webcast
Differences between the parent guideline (CPG) and the PAGA: Genetics, biology and practice differences between West and Asia
Presenter: Elizabeth Smyth
Session: Practicing oncology across the globe: ESMO Clinical Practice Guidelines and Pan Asian adaptations (in collaboration with TOS, ISMPO, KSMO)
Resources:
Slides
Webcast
What do translational analytics teach us about IO therapy in solid tumours
Presenter: Kai-Keen Shiu
Session: Have we seen everything from checkpoints inhibitors?
Resources:
Slides
Webcast
Is there a role for radiotherapy de-intensification?
Presenter: Pierre Blanchard
Session: Nasopharyngeal cancer (NPC): Treatment strategies for locally advanced disease
Resources:
Slides
Webcast
Other synthetic lethality targets
Presenter: Ruth Plummer
Session: Targeting DNA damage response (DDR): Next generation drugs and the importance of biomarkers
Resources:
Slides
Webcast
Q&A and discussion
Session: Practicing oncology across the globe: ESMO Clinical Practice Guidelines and Pan Asian adaptations (in collaboration with TOS, ISMPO, KSMO)
Resources:
Webcast
Interactive discussion: Everything you wanted to know about IO but never dared to ask
Session: Have we seen everything from checkpoints inhibitors?
Resources:
Webcast